Prev：Implication of an exosome-based gene signature for estimating clinical outcomes of triple-negative breast cancer and assisting in individualized therapy(BMU101-3.9)
Next：Implications of CRNDE in prognosis, tumor immunity, and therapeutic sensitivity in low grade glioma patients(KTA0002-3)
